Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
40
TGA:40
Drug Approvals
Australia Propolis Capsules (410490)
- Product Name
- Australia Propolis Capsules
- Approval Date
- Jun 14, 2023
TGA
Lifetime Pharmaceuticals Propolis 6000 mg (392534)
- Product Name
- Lifetime Pharmaceuticals Propolis 6000 mg
- Approval Date
- Jul 20, 2022
TGA
Lifetime Antarctic Krill Oil - Premium Gold (318990)
- Product Name
- Lifetime Antarctic Krill Oil - Premium Gold
- Approval Date
- Jun 17, 2019
TGA
Premium Gold Inner Health Probiotics 50 Billion (310459)
- Product Name
- Premium Gold Inner Health Probiotics 50 Billion
- Approval Date
- Oct 17, 2018
TGA
Osteo-Premium Gold VD3 Complex (309583)
- Product Name
- Osteo-Premium Gold VD3 Complex
- Approval Date
- Sep 24, 2018
TGA
Lifetime Lung Care Formula (304085)
- Product Name
- Lifetime Lung Care Formula
- Approval Date
- Jun 8, 2018
TGA
Lifetime PLACENTA 12,000 Premium Gold Baby Sheep (303316)
- Product Name
- Lifetime PLACENTA 12,000 Premium Gold Baby Sheep
- Approval Date
- May 22, 2018
TGA
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule (301007)
- Product Name
- Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule
- Approval Date
- Mar 19, 2018
TGA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Beta Alethine in Treating Patients With Myeloma
Phase 1
- Conditions
- Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00006466
- Locations
- 🇺🇸
Emory Clinic, Atlanta, Georgia, United States
🇺🇸Victory Over Cancer, Rockville, Maryland, United States
🇺🇸St. Vincents Comprehensive Cancer Center, New York, New York, United States
Beta Alethine in Treating Patients With Low-Grade Lymphoma
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00007839
- Locations
- 🇺🇸
Victory Over Cancer, Rockville, Maryland, United States
Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00041379
- Locations
- 🇺🇸
Victory Over Cancer, Rockville, Maryland, United States
News
No news found